Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - alendronate sodium monohydrate, quantity: 81.24 mg (equivalent: alendronic acid, qty 70 mg) - tablet, uncoated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; lactose monohydrate; magnesium stearate - treatment of osteoporosis, including glucocorticoid induced osteoporosis. osteoporosis must be confirmed by the finding of low bone mass of at least two standard deviations below the gender specific mean for young adults or by the presence of history of osteoporotic fracture. paget's disease of bone.

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - paracetamol, quantity: 450 mg; codeine phosphate hemihydrate, quantity: 30 mg; doxylamine succinate, quantity: 5 mg - tablet, uncoated - excipient ingredients: purified talc; microcrystalline cellulose; magnesium stearate; sodium starch glycollate; hypromellose - mevadol forte is indicated for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

sundew solutions pty ltd - fipronil - granular formulation - fipronil nitrile active 0.25 g/kg - insecticide - ant track or nest pest control | bowling and golf green turf | commercial building/structure - external | commercial turf grass - ant | funnel ant | argentine ant | pharaoh ant

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

farmalinx pty ltd - metaldehyde - bait - metaldehyde aldehyde active 15.0 g/kg - molluscicide - around plants and/or border areas - common slug | snail | bradybaena similaris | deroceras caruanae | helix aspersa | sigmurethra | theba pisana

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

turf culture pty ltd - bifenthrin - granular formulation - bifenthrin pyrethroid active 2.0 g/kg - insecticide - bowling green | commercial building/structure - external | domestic building/structure - external a | lawn | recreational land | - african black beetle | argentine stem weevil | bill bug | black or black house ant | coastal brown ant | flea | funnel ant | ixodes spp. | lawn armyworm | sod webworm | stinging ant | sugar ant | banded sugar ant | billbug | ctenocephalides spp. | grass caterpillar | grass grub | ground fleas | la plata weevil | lawn caterpillar | madeira ant | ochetellus glaber

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

evergreen garden care australia pty ltd - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.0 g/kg - molluscicide - garden - common slug | snail | bradybaena similaris | deroceras caruanae | helix aspersa | sigmurethra | theba pisana

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

inca (flight) co pty ltd - n-octyl bicycloheptene dicarboximide; di-n-propyl isocinchomeronate; piperonyl butoxide; diethyltoluamide; citronella oil; pyrethrins - topical aerosol spray - n-octyl bicycloheptene dicarboximide bicyclo active 18.0 g/l; di-n-propyl isocinchomeronate benzene active 18.0 g/l; piperonyl butoxide benzodioxole active 10.0 g/l; diethyltoluamide insect repellent active 18.0 g/l; citronella oil oil-plant extract active 5.0 g/l; pyrethrins pyrethroid-pyrethrin active 1.0 g/l - parasiticides - cattle | dog | empty animal and/or bird housing/cage | horse | kennel, animal living area pest control | piggery | pigs | stable - fly | mosquito | adult mosquitoes

Austrálie - angličtina - APVMA (Australian Pesticides and Veterinary Medicines Authority)

crop smart pty ltd - metaldehyde - pellet (eg snail bait) - metaldehyde aldehyde active 15.0 g/kg - molluscicide

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - lenvatinib mesilate, quantity: 12.25 mg (equivalent: lenvatinib, qty 10 mg) - capsule, hard - excipient ingredients: microcrystalline cellulose; iron oxide yellow; purified talc; iron oxide red; calcium carbonate; propylene glycol; hyprolose; mannitol; potassium hydroxide; titanium dioxide; hypromellose; iron oxide black; shellac - endometrial carcinoma lenvima, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability-high (msi-h) or mismatch repair deficient (dmmr), who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation., differentiated thyroid cancer (dtc) lenvima is indicated for the treatment of patients with progressive, locally advanced or metastatic, radioactive iodine (rai) refractory differentiated thyroid cancer (dtc).,renal cell carcinoma (rcc) lenvima, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (rcc).,lenvima, in combination with everolimus, is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) whose disease has progressed following one prior vascular endothelial growth factor targeted therapy.,hepatocellular carcinoma (hcc) lenvima is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (hcc).

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

eisai australia pty ltd - lenvatinib mesilate, quantity: 4.9 mg (equivalent: lenvatinib, qty 4 mg) - capsule, hard - excipient ingredients: iron oxide yellow; propylene glycol; potassium hydroxide; mannitol; iron oxide black; titanium dioxide; hypromellose; purified talc; iron oxide red; calcium carbonate; microcrystalline cellulose; hyprolose; shellac - endometrial carcinoma lenvima, in combination with pembrolizumab, is indicated for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability-high (msi-h) or mismatch repair deficient (dmmr), who have disease progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.,differentiated thyroid cancer (dtc) lenvima is indicated for the treatment of patients with progressive, locally advanced or metastatic, radioactive iodine (rai) refractory differentiated thyroid cancer (dtc).,renal cell carcinoma (rcc) lenvima, in combination with pembrolizumab, is indicated for the first-line treatment of adult patients with advanced renal cell carcinoma (rcc).,lenvima, in combination with everolimus, is indicated for the treatment of adult patients with advanced renal cell carcinoma (rcc) whose disease has progressed following one prior vascular endothelial growth factor targeted therapy.,hepatocellular carcinoma (hcc) lenvima is indicated for the first-line treatment of patients with unresectable hepatocellular carcinoma (hcc).